Hosted on MSN19m
Leerink Partners Downgrades Lexicon Pharmaceuticals (LXRX)Fintel reports that on March 4, 2025, Leerink Partners downgraded their outlook for Lexicon Pharmaceuticals (NasdaqGS:LXRX) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback